Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Medtronic, Inc. (NYSE:MDT) today closed the sale of its Physio-Control defibrillator business to Bain Capital for $478 million in cash.
Coming on the heels of the French breast implant controversy, a senior manager at Nuffield Health hospital in Germany warned the country’s doctors to avoid a second type of breast implant called Silimed.
Six of the so-called “FDA 9” whistleblowers are suing the federal watchdog agency, alleging that the government violated their constitutional rights with surveillance of their private email accounts.